Lisa M. Greene

2.1k citations

35 papers · 1.7k indexed · h-index 21

Co-authors: Daniela M. Zisterer Mary J. Meegan William M. Gallagher W. Scott Argraves Marion A. Cooley Niamh M. O’Boyle Stephen A. McClave Harvy L. Snider
Topics: Synthesis of β-Lactam Compounds (10 papers)Synthesis and Biological Activity (9 papers)Cancer therapeutics and mechanisms (7 papers)
Cited by: Organic Chemistry Nutrition and Dietetics Cancer Research
Journals: Cancer Research FEBS Letters Journal of Medicinal Chemistry
Partner nations: Ireland United States Italy

In The Last Decade

Lisa M. Greene

35 papers receiving 1.7k citations

Peers

Countries citing papers authored by Lisa M. Greene

Since Specialization

Citations

This map shows the geographic impact of Lisa M. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Greene more than expected).

Fields of papers citing papers by Lisa M. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Greene. The network helps show where Lisa M. Greene may publish in the future.

Co-authorship network of co-authors of Lisa M. Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Greene. A scholar is included among the top collaborators of Lisa M. Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Greene. Lisa M. Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells 2018 ·Investigational New Drugs ·(unknown),Lisa M. Greene,Seema M. Nathwani,Paula Kinsella,Niamh M. O’Boyle,Mary J. Meegan,Daniela M. Zisterer	4
2	β-Lactam analogues of combretastatin A-4 prevent metabolic inactivation by glucuronidation in chemoresistant HT-29 colon cancer cells 2017 ·European Journal of Medicinal Chemistry ·Azizah M. Malebari,Lisa M. Greene,Seema M. Nathwani,Darren Fayne,Niamh M. O’Boyle,Shu Wang,Brendan Twamley,Daniela M. Zisterer,Mary J. Meegan	39
3	The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15 2016 ·Investigational New Drugs ·Paula Kinsella,Lisa M. Greene,Sandra A. Bright,(unknown),Stefania Butini,Giuseppe Campiani,Sebastian Bauer,D. Clive Williams,Daniela M. Zisterer	5
4	The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL-induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells 2016 ·International Journal of Oncology ·(unknown),Lisa M. Greene,Stefania Butini,Giuseppe Campiani,D. Clive Williams,Afshin Samali,Éva Szegezdi,Daniela M. Zisterer	20
5	Combretastatins: More Than Just Vascular Targeting Agents? 2015 ·Journal of Pharmacology and Experimental Therapeutics ·Lisa M. Greene,Mary J. Meegan,Daniela M. Zisterer	71
6	Combretazet-3 a novel synthetic cis-stable combretastatin A-4- azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer 2013 ·Oncology Reports ·Lisa M. Greene,Shu Wang,Niamh M. O’Boyle,Sandra A. Bright,Jane Reid,(unknown),Mary J. Meegan,Daniela M. Zisterer	18
7	Inhibition of late-stage autophagy synergistically enhances pyrrolo-1,5-benzoxazepine-6-induced apoptotic cell death in human colon cancer cells 2013 ·International Journal of Oncology ·Lisa M. Greene,Derek P. Nolan,Daniel Regan-Komito,Giuseppe Campiani,D. Clive Williams,Daniela M. Zisterer	21
8	Synthesis and biochemical activities of antiproliferative amino acid and phosphate derivatives of microtubule-disrupting β-lactam combretastatins 2013 ·European Journal of Medicinal Chemistry ·Niamh M. O’Boyle,Lisa M. Greene,(unknown),Shu Wang,(unknown),Daniela M. Zisterer,Mary J. Meegan	23
9	The vascular targeting agent Combretastatin-A4 directly induces autophagy in adenocarcinoma-derived colon cancer cells 2012 ·Biochemical Pharmacology ·Lisa M. Greene,Niamh M. O’Boyle,Derek P. Nolan,Mary J. Meegan,Daniela M. Zisterer	42
10	Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe 2011 ·European Journal of Medicinal Chemistry ·Niamh M. O’Boyle,M.J. Carr,Lisa M. Greene,(unknown),Andrew J. S. Knox,Thomas McCabe,David G. Lloyd,Daniela M. Zisterer,Mary J. Meegan	38
11	Lead identification of conformationally restricted β-lactam type combretastatin analogues: Synthesis, antiproliferative activity and tubulin targeting effects 2010 ·European Journal of Medicinal Chemistry ·M.J. Carr,Lisa M. Greene,Andrew J. S. Knox,David G. Lloyd,Daniela M. Zisterer,Mary J. Meegan	63
12	The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia 2009 ·Cancer Research ·(unknown),(unknown),Lisa M. Greene,Siobhan McGuckin,(unknown),Paul Browne,Stefania Butini,Giuseppe Campiani,Mark Catherwood,Elisabeth Vandenberghe,D. Clive Williams,Daniela M. Zisterer,Mark Lawler	30
13	The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells 2008 ·Biochemical Pharmacology ·Sandra A. Bright,Lisa M. Greene,(unknown),Giuseppe Campiani,Stefania Butini,Margherita Brindisi,Mark Lawler,Mary J. Meegan,D. Clive Williams,Daniela M. Zisterer	9
14	BubR1 Is Required for a Sustained Mitotic Spindle Checkpoint Arrest in Human Cancer Cells Treated with Tubulin-Targeting Pyrrolo-1,5-Benzoxazepines 2007 ·Molecular Pharmacology ·Lisa M. Greene,Giuseppe Campiani,Mark Lawler,D. Clive Williams,Daniela M. Zisterer	35
15	STI-571 (Imatinib Mesylate) Enhances the Apoptotic Efficacy of Pyrrolo-1,5-Benzoxazepine-6, a Novel Microtubule-Targeting Agent, in Both STI-571-Sensitive and -Resistant Bcr-Abl-Positive Human Chronic Myeloid Leukemia Cells 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Lisa M. Greene,Liam Kelly,(unknown),Giuseppe Campiani,Mark Lawler,D. Clive Williams,Daniela M. Zisterer	20
16	Identification of Tubulin as the Molecular Target of Proapoptotic Pyrrolo-1,5-benzoxazepines 2006 ·Molecular Pharmacology ·Jude M. Mulligan,Lisa M. Greene,Suzanne M. Cloonan,Margaret M. Mc Gee,(unknown),Giuseppe Campiani,Caterina Fattorusso,Mark Lawler,D. Clive Williams,Daniela M. Zisterer	52
17	The pyrrolo-1,5-benzoxazepine, PBOX-6, inhibits the growth of breast cancer cells in vitro independent of estrogen receptor status and inhibits breast tumour growth in vivo 2005 ·Oncology Reports ·Lisa M. Greene,Marina N. Fleeton,Jude M. Mulligan,(unknown),B. J. Sheahan,Gregory J. Atkins,Giuseppe Campiani,Vito Nacci,Mark Lawler,D. Clive Williams,Daniela M. Zisterer	18
18	Selective Induction of Apoptosis by the Pyrrolo-1,5-benzoxazepine 7-[{Dimethylcarbamoyl}oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia Cells Occurs via the c-Jun NH2-Terminal Kinase-Dependent Phosphorylation and Inactivation of Bcl-2 and Bcl-XL 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Margaret M. Mc Gee,Lisa M. Greene,(unknown),Giuseppe Campiani,Vito Nacci,Mark Lawler,D. Clive Williams,Daniela M. Zisterer	28
19	Elevated expression and altered processing of fibulin-1 protein in human breast cancer 2003 ·British Journal of Cancer ·Lisa M. Greene,Waleed O. Twal,Michael J. Duffy,E. McDermott,Arnold Hill,N. J. O’Higgins,Amanda McCann,P. Dervan,W. Scott Argraves,William M. Gallagher	65
20	Nutritional support in patients with inflammatory bowel disease 1992 ·Postgraduate Medicine ·Cynthia C. Lowen,Lisa M. Greene,Stephen A. McClave	4

About Lisa M. Greene

Lisa M. Greene is a scholar working on Cancer Research, Organic Chemistry and Physiology, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include Synthesis of β-Lactam Compounds (10 papers), Synthesis and Biological Activity (9 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Organic Chemistry (606 citations), Nutrition and Dietetics (312 citations) and Cancer Research (230 citations). Lisa M. Greene has collaborated with scholars based in Ireland, United States and Italy. Frequent co-authors include Daniela M. Zisterer, Mary J. Meegan, William M. Gallagher, W. Scott Argraves, Marion A. Cooley, Niamh M. O’Boyle, Stephen A. McClave, Harvy L. Snider, L Makk and L. Jane Goldsmith. Their work appears in journals such as Cancer Research, FEBS Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact